A new study reveals how mutations in the NEK1 gene contribute to amyotrophic lateral sclerosis. Research shows that these specific mutations cause the body to produce a shorter version of the NEK1 protein. Unlike the standard protein that resides in the cytoplasm, this truncated version accumulates inside the nucleolus of the cell.
The nucleolus is responsible for creating ribosomes, which function as the primary machinery for protein production. When these truncated proteins build up, they form abnormal clumps that stop the cell from generating new ribosomes. This failure in cellular maintenance leads to impaired protein production and eventual cell death.
Experiments performed on lab-grown human cells confirmed that these protein clusters disrupt ribosomal RNA creation. Similar tests involving fruit flies and mice demonstrated a direct link between these mutations and motor dysfunction, as well as reduced survival rates. These findings indicate that the breakdown of RNA metabolism is a significant pathway in the progression of this disease.
This discovery offers a clearer view of the biological mechanics behind NEK1-related ALS cases. By identifying this mechanism, researchers now possess a specific target for future investigation into disease treatment. While further validation in human patients remains necessary, the evidence suggests a consistent pattern of damage across multiple models.